Patron Partners LLC Sells 5,521 Shares of Stryker Corporation $SYK

Patron Partners LLC reduced its holdings in shares of Stryker Corporation (NYSE:SYK – Free Report) by 81.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,271 shares of the medical technology company’s stock after selling 5,521 shares during the period. Patron Partners LLC’s holdings in Stryker were worth $350,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in SYK. Gables Capital Management Inc. purchased a new stake in shares of Stryker in the 2nd quarter worth $25,000. Kilter Group LLC bought a new stake in Stryker during the second quarter valued at about $25,000. Cornerstone Financial Management LLC increased its position in Stryker by 66.0% in the second quarter. Cornerstone Financial Management LLC now owns 78 shares of the medical technology company’s stock worth $25,000 after buying an additional 31 shares in the last quarter. Highland Investment Advisors LLC purchased a new stake in Stryker in the second quarter worth about $25,000. Finally, Compass Financial Management LLC bought a new position in shares of Stryker in the second quarter worth about $27,000. 77.09% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on SYK. Wall Street Zen cut Stryker from a “buy” rating to a “hold” rating in a research report on Saturday, October 3rd. JPMorgan Chase & Co. decreased their target price on shares of Stryker from $350.00 to $340.00 and set an “overweight” rating on the stock in a research note on Friday, October 30th. TD Cowen lowered their price target on shares of Stryker from $298.00 to $290.00 and set a “hold” rating on the stock in a report on Friday, October 30th. Canaccord Genuity Group lowered shares of Stryker from a “buy” rating to a “hold” rating and dropped their price target for the stock from $385.00 to $300.00 in a research report on Friday, October 30th. Finally, Citigroup reissued a “market outperform” rating on shares of Stryker in a research note on Friday, October 30th. Twenty-one equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $343.77.

Read Our Latest Report on Stryker

Insider Activity

In related news, Director Ronda Stryker sold 550,000 shares of the company’s stock in a transaction on Friday, November 6th. The shares were sold at an average price of $325.32, for a total transaction of $178,926,000.00. Following the completion of the transaction, the director owned 1,701,375 shares in the company, valued at approximately $553,491,315. This represents a 24.43% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 4.60% of the stock is currently owned by insiders.

Stryker Stock Down 1.0%

Shares of SYK opened at $309.91 on Friday. The business’s 50 day moving average is $295.66 and its 200 day moving average is $321.39. The company has a current ratio of 2.18, a quick ratio of 1.30 and a debt-to-equity ratio of 0.60. Stryker Corporation has a 12-month low of $267.00 and a 12-month high of $389.33. The company has a market capitalization of $117.98 billion, a PE ratio of 33.00, a price-to-earnings-growth ratio of 2.13 and a beta of 0.78.

Stryker (NYSE:SYK – Get Free Report) last posted its quarterly earnings results on Thursday, October 29th. The medical technology company reported $3.52 earnings per share for the quarter, missing the consensus estimate of $3.55 by ($0.03). Stryker had a return on equity of 23.74% and a net margin of 13.78%. The business had revenue of $6.52 billion during the quarter, compared to the consensus estimate of $6.62 billion. During the same quarter in the previous year, the company earned $3.19 earnings per share. The company’s revenue for the quarter was up 7.6% compared to the same quarter last year. Research analysts expect that Stryker Corporation will post 14.85 earnings per share for the current fiscal year.

About Stryker

(Free Report)

Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings. The company’s products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.

Further Reading

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK – Free Report).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.